Genzyme agrees ceasefire with major shareholder
This article was originally published in Scrip
Executive Summary
Genzyme has agreed a truce with an activist investor and could relinquish a board seat as the firm shores up support for its management. The biotech, which has had a fraught time with investors, has signed a "mutual cooperation agreement" with Relational Investors, a major shareholder.